Lyell Immunopharma, Inc. (LYEL) Insider Trading

Over the last 3 months, LYEL insiders made 0 open-market buys and 14 sales, a net sale of -$246K (SEC Form 4). Over the last 6 months, 23 institutions increased and 10 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
14
Net (3m)
-$245.5K
Insider trades by month Buys Sells
Jan
Feb
Mar
Jun
Jul
Aug
Context3-month price -16.9%Institutions reducing (13F)
DateInsiderTypeSharesPrice
Aug 25, 2026Hill Stephen J.officer: Chief Operating OfficerSell989$15.54
Aug 25, 2026Lee Gary K.officer: Chief Scientific OfficerSell1,457$15.54
Aug 25, 2026Seely Lynndirector, officer: President and CEOSell9,589$15.54
Aug 11, 2026Lee Gary K.officer: Chief Scientific OfficerSell131$14.34
Aug 11, 2026Bulis Veronica Sanchezofficer: VP, Corporate ControllerSell621$14.34
Aug 11, 2026Seely Lynndirector, officer: President and CEOSell390$14.34
Aug 11, 2026Hill Stephen J.officer: Chief Operating OfficerSell89$14.34
Jul 20, 2026Innovative Cellular Therapeutics Holdings Ltd10 percent ownerSell10$13.70
Jul 17, 2026Innovative Cellular Therapeutics Holdings Ltd10 percent ownerSell10$13.73
Jun 15, 2026Seely Lynndirector, officer: President and CEOSell388$18.91
Jun 15, 2026Bulis Veronica Sanchezofficer: VP, Corporate ControllerSell217$18.91
Jun 15, 2026Hill Stephen J.officer: Chief Operating OfficerSell89$18.92
Jun 15, 2026Lee Gary K.officer: Chief Scientific OfficerSell130$18.92
Jun 12, 2026Bachleda MarkdirectorGrant9,250$13.22
Jun 12, 2026NABEL ELIZABETH GdirectorGrant9,250$13.22
Jun 12, 2026Klausner RicharddirectorGrant9,250$13.22
Jun 12, 2026RIEFLIN WILLIAM JLdirectorGrant9,250$13.22
Jun 12, 2026Ramachandra SumantdirectorGrant9,250$13.22
Jun 12, 2026FRIEDMAN CATHYdirectorGrant9,250$13.22
Jun 12, 2026BRAWLEY OTIS WdirectorGrant9,250$13.22
Jun 11, 2026Shook Davidofficer: Chief Medical OfficerSell1,977$12.64
Mar 16, 2026Shah Smitalofficer: Chief Fin. and Bus. OfficerGrant140,000$25.50
Mar 9, 2026ARCH Venture Partners IX, LLC10 percent ownerBuy488,090$25.61
Mar 9, 2026ARCH Venture Fund XIII, L.P.10 percent ownerBuy488,090$25.61
Feb 12, 2026Seely Lynndirector, officer: President and CEOSell7,455$23.39
Feb 12, 2026Lee Gary K.officer: Chief Scientific OfficerSell1,671$23.39
Feb 12, 2026Hill Stephen J.officer: Chief Operating OfficerSell1,236$23.39
Feb 11, 2026Hill Stephen J.officer: Chief Operating OfficerGrant65,000$23.71
Feb 11, 2026Hill Stephen J.officer: Chief Operating OfficerGrant4,000
Feb 11, 2026Hill Stephen J.officer: Chief Operating OfficerSell109$23.12

Source: LYEL SEC Form 4 filings, latest Aug 25, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their LYEL positions over the last 6 months (SEC Form 13F).

Increased
23
New positions
20
Reduced
10
Sold out
76
Largest moves
InstitutionActionSharesFiled
ARCH VENTURE MANAGEMENT, LLCIncreased3.2MMay 15, 2026
GSK PLCUnchanged1.5MMay 14, 2026
FORESITE CAPITAL MANAGEMENT IV, LLCUnchanged800KMay 15, 2026
ORLAND PROPERTIES LTDUnchanged755KMay 6, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position718KMay 15, 2026
ALMITAS CAPITAL LLCUnchanged578KMay 15, 2026
FORESITE CAPITAL MANAGEMENT V, LLCUnchanged477KMay 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased459KMay 15, 2026
CITADEL ADVISORS LLCIncreased393KMay 15, 2026
VENBIO PARTNERS LLCUnchanged338KMay 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased310KMay 15, 2026
ALPHABET INC.Unchanged293KMay 8, 2026
BLACKROCK, INC.Increased192KMay 13, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased167KMay 15, 2026
SC CHINA HOLDING LTDUnchanged152KMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.